ES446411A1 - Un metodo para preparar 17 alfa-ester-21-halo-pregnanos - Google Patents

Un metodo para preparar 17 alfa-ester-21-halo-pregnanos

Info

Publication number
ES446411A1
ES446411A1 ES446411A ES446411A ES446411A1 ES 446411 A1 ES446411 A1 ES 446411A1 ES 446411 A ES446411 A ES 446411A ES 446411 A ES446411 A ES 446411A ES 446411 A1 ES446411 A1 ES 446411A1
Authority
ES
Spain
Prior art keywords
alpha
pregnanes
halo
ester
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446411A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of ES446411A1 publication Critical patent/ES446411A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES446411A 1975-03-31 1976-03-26 Un metodo para preparar 17 alfa-ester-21-halo-pregnanos Expired ES446411A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (1)

Publication Number Publication Date
ES446411A1 true ES446411A1 (es) 1979-02-01

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446411A Expired ES446411A1 (es) 1975-03-31 1976-03-26 Un metodo para preparar 17 alfa-ester-21-halo-pregnanos

Country Status (14)

Country Link
US (1) US4113680A (US07223432-20070529-C00017.png)
CA (1) CA1044225A (US07223432-20070529-C00017.png)
CH (1) CH609709A5 (US07223432-20070529-C00017.png)
DE (1) DE2613875A1 (US07223432-20070529-C00017.png)
DK (1) DK141171B (US07223432-20070529-C00017.png)
ES (1) ES446411A1 (US07223432-20070529-C00017.png)
FR (1) FR2306214A1 (US07223432-20070529-C00017.png)
GB (1) GB1508517A (US07223432-20070529-C00017.png)
HU (1) HU174850B (US07223432-20070529-C00017.png)
IN (1) IN142583B (US07223432-20070529-C00017.png)
NL (1) NL7603249A (US07223432-20070529-C00017.png)
PT (1) PT64885B (US07223432-20070529-C00017.png)
SE (1) SE403380B (US07223432-20070529-C00017.png)
YU (1) YU54476A (US07223432-20070529-C00017.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (US07223432-20070529-C00017.png) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH609709A5 (US07223432-20070529-C00017.png) 1979-03-15
YU54476A (en) 1982-05-31
US4113680A (en) 1978-09-12
IN142583B (US07223432-20070529-C00017.png) 1977-07-30
FR2306214B1 (US07223432-20070529-C00017.png) 1981-04-30
DK141171C (US07223432-20070529-C00017.png) 1980-07-07
SE403380B (sv) 1978-08-14
GB1508517A (en) 1978-04-26
NL7603249A (nl) 1976-10-04
DK144076A (US07223432-20070529-C00017.png) 1976-10-01
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
CA1044225A (en) 1978-12-12
FR2306214A1 (fr) 1976-10-29
PT64885B (en) 1977-11-17
DE2613875A1 (de) 1976-10-14
DK141171B (da) 1980-01-28
HU174850B (hu) 1980-03-28

Similar Documents

Publication Publication Date Title
ES446411A1 (es) Un metodo para preparar 17 alfa-ester-21-halo-pregnanos
ES465742A1 (es) Un procedimiento para la preparacion de nuevas pirazincar- boxamidas.
FR2314197A1 (fr) Procede de preparation d'oxo-20 steroides insatures en 9,11
DK139031B (da) Analogifremgangsmåde til fremstilling af i 21-stillingen alkylerede 3,20-dioxo-delta4-steroider af pregnanrækken.
NL7606093A (nl) Werkwijze voor de microbiologische oxydatie van steroiden.
DK131474B (da) Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater.
NL168547C (nl) Werkwijze voor het bereiden van een luminescerend materiaal; kathode luminescerende inrichting.
DK129039B (da) Fremgangsmåde til fremstilling af 11β,16α17α21-tetrahydroxy-pregna-1,4-dien-3,20-dioner eller de tilsvarende 16,17-acetonider.
NL7601434A (nl) Werkwijze voor het bereiden van 9(beta),10(alpha)-choles- ta-5,7-dieen-3(beta), 25 diol en 25-hydroxyprevita- mine d3.
ES447942A1 (es) Procedimiento para preparar derivados de cilopentano.
JPS51148178A (en) A trouble diagnosis system
JPS5211810A (en) Automatic setting system of auto-announce equipment
DK140847B (da) Analogifremgangsmåde til fremstilling af 2,2-dimethyl-pregn-4-en-3,20-dioner.
JPS51118936A (en) Constant phase filtration method
JPS51145292A (en) Location finding system
JPS5230718A (en) Process for making metallic material with high toughness
AU499324B2 (en) D-homo pregna 1, 4 diene-3, 11, 20 trione derivatives
JPS523394A (en) Piezo-vibrator
AU2254470A (en) A process for the selective 3-or 9(11)-enolisation of a steroid 1, 4-diene-3, 11-dione
CA908157A (en) PROCESS FOR PREPARING USEFUL 17.alpha.-HYDROXY-20-KETO AND 17.alpha., 21-DIHYDROXY-20-KETO PREGNANES AND DERIVATIVES AND INTERMEDIATES THEREOF
CA700410A (en) METHOD OF PREPARING SUBSTITUTED 21-SULFONYLOXY-16.alpha.,17.alpha.-DIHYDROXY STEROIDS OF THE PREGNANE SERIES
CA709852A (en) 9.alpha.,16-DIFLUORO COMPOUNDS OF THE PREGNANE SERIES AND PROCESS FOR THE PRODUCTION THEREOF
CA865734A (en) RING A UNSATURATED 6,16-DIMETHYL-11-OXYGENATED-PREGNANE-17.alpha.,21-DIOL-3,20-DIONES AND PROCESS
JPS51147157A (en) Negative feedback amplifier
CA560164A (en) Pregnane-3,7,20-trione

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981001